Emi Ishikawa

1.0k total citations
40 papers, 826 citations indexed

About

Emi Ishikawa is a scholar working on Hepatology, Epidemiology and Oncology. According to data from OpenAlex, Emi Ishikawa has authored 40 papers receiving a total of 826 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hepatology, 13 papers in Epidemiology and 6 papers in Oncology. Recurrent topics in Emi Ishikawa's work include Liver Disease Diagnosis and Treatment (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (11 papers) and Hepatitis C virus research (6 papers). Emi Ishikawa is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (11 papers) and Hepatitis C virus research (6 papers). Emi Ishikawa collaborates with scholars based in Japan, United States and China. Emi Ishikawa's co-authors include Masatoshi Kudo, Kazuomi Ueshima, Tatsuo Inoue, Satoshi Kitai, Yasunori Minami, Hobyung Chung, Satoru Hagiwara, Taisuke Ueda, Chie Tatsumi and Norihisa Yada and has published in prestigious journals such as Journal of Biological Chemistry, Scientific Reports and Brain Research.

In The Last Decade

Emi Ishikawa

40 papers receiving 808 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emi Ishikawa Japan 18 521 370 145 93 92 40 826
Yoriko Murata Japan 13 133 0.3× 156 0.4× 64 0.4× 64 0.7× 76 0.8× 44 646
Kyu Ri Son South Korea 17 180 0.3× 128 0.3× 207 1.4× 71 0.8× 61 0.7× 40 675
Tao Sun China 18 215 0.4× 126 0.3× 166 1.1× 167 1.8× 80 0.9× 67 850
Masato Takahashi Japan 14 240 0.5× 161 0.4× 120 0.8× 118 1.3× 181 2.0× 38 836
Ping Cai China 12 135 0.3× 114 0.3× 175 1.2× 98 1.1× 26 0.3× 34 614
Makoto Takeda Japan 13 83 0.2× 155 0.4× 134 0.9× 136 1.5× 60 0.7× 106 718
Alexander Wehr Germany 8 361 0.7× 505 1.4× 116 0.8× 159 1.7× 44 0.5× 10 993
Xiaopan Wu China 18 259 0.5× 346 0.9× 55 0.4× 219 2.4× 43 0.5× 38 829
Mark Li United States 13 43 0.1× 171 0.5× 152 1.0× 111 1.2× 34 0.4× 24 630
Michele Vincitore United States 11 63 0.1× 456 1.2× 119 0.8× 69 0.7× 69 0.8× 18 841

Countries citing papers authored by Emi Ishikawa

Since Specialization
Citations

This map shows the geographic impact of Emi Ishikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emi Ishikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emi Ishikawa more than expected).

Fields of papers citing papers by Emi Ishikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emi Ishikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emi Ishikawa. The network helps show where Emi Ishikawa may publish in the future.

Co-authorship network of co-authors of Emi Ishikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Emi Ishikawa. A scholar is included among the top collaborators of Emi Ishikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emi Ishikawa. Emi Ishikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ishikawa, Emi, et al.. (2023). Distinct Situational Cue Processing in Individuals with Kleptomania: A Preliminary Study. The International Journal of Neuropsychopharmacology. 26(5). 340–349. 2 indexed citations
2.
Ishikawa, Emi, et al.. (2021). Comparable level of aggression between patients with behavioural addiction and healthy subjects. Translational Psychiatry. 11(1). 375–375. 5 indexed citations
3.
Ishikawa, Emi, et al.. (2020). Monoamine and genome-wide DNA methylation investigation in behavioral addiction. Scientific Reports. 10(1). 11760–11760. 6 indexed citations
4.
Ueshima, Kazuomi, Masatoshi Kudo, Masahiro Takita, et al.. (2011). Des-γ-Carboxyprothrombin May Be a Promising Biomarker to Determine the Therapeutic Efficacy of Sorafenib for Hepatocellular Carcinoma. Digestive Diseases. 29(3). 321–325. 44 indexed citations
5.
Yada, Norihisa, Masatoshi Kudo, Hobyung Chung, et al.. (2010). PEG-IFNα/RBV Combination Therapy for Chronic Hepatitis C Patients Increases Serum Ferritin Level while It Improves Sustained Viral Response Rate. Intervirology. 53(1). 60–65. 6 indexed citations
6.
Hatanaka, Kinuyo, Hobyung Chung, Masatoshi Kudo, et al.. (2010). Usefulness of the Post-Vascular Phase of Contrast-Enhanced Ultrasonography with Sonazoid in the Evaluation of Gross Types of Hepatocellular Carcinoma. Oncology. 78(Suppl. 1). 53–59. 28 indexed citations
7.
Ueda, Taisuke, Hobyung Chung, Masatoshi Kudo, et al.. (2010). Prolonged PEG-IFN and RBV Is Effective in Patients with HCV Genotype 1 and High Viral Load Who Achieved Virological Response Later than 24 Weeks. Intervirology. 53(1). 55–59. 3 indexed citations
8.
Inoue, Tatsuo, Yasunori Minami, Hobyung Chung, et al.. (2010). Radiofrequency Ablation for Hepatocellular Carcinoma: Assistant Techniques for Difficult Cases. Oncology. 78(Suppl. 1). 94–101. 21 indexed citations
9.
Ueshima, Kazuomi, Masatoshi Kudo, Masahiro Takita, et al.. (2010). Hepatic Arterial Infusion Chemotherapy Using Low-Dose 5-Fluorouracil and Cisplatin for Advanced Hepatocellular Carcinoma. Oncology. 78(Suppl. 1). 148–153. 76 indexed citations
10.
Inoue, Tatsuo, Masatoshi Kudo, Kinuyo Hatanaka, et al.. (2008). Imaging of Hepatocellular Carcinoma: Qualitative and Quantitative Analysis of Postvascular Phase Contrast-Enhanced Ultrasonography with Sonazoid. Oncology. 75(Suppl. 1). 48–54. 32 indexed citations
11.
Kudo, Masatoshi, Hobyung Chung, Emi Ishikawa, et al.. (2008). Elevated Serum ALT Levels during Pegylated Interferon Monotherapy May Be Caused by Hepatic Iron Overload. Intervirology. 51(Suppl. 1). 76–85. 10 indexed citations
12.
Kitai, Satoshi, Masatoshi Kudo, Yasunori Minami, et al.. (2008). A New Prognostic Staging System for Hepatocellular Carcinoma: Value of the Biomarker Combined Japan Integrated Staging Score. Intervirology. 51(Suppl. 1). 86–94. 32 indexed citations
13.
Takahashi, Shunsuke, Masatoshi Kudo, Hobyung Chung, et al.. (2007). Initial Treatment Response Is Essential to Improve Survival in Patients with Hepatocellular Carcinoma Who Underwent Curative Radiofrequency Ablation Therapy. Oncology. 72(Suppl. 1). 98–103. 74 indexed citations
14.
Kudo, Masatoshi, Yasuhiro Sakaguchi, Hobyung Chung, et al.. (2007). Long-Term Interferon Maintenance Therapy Improves Survival in Patients with HCV-Related Hepatocellular Carcinoma after Curative Radiofrequency Ablation. Oncology. 72(Suppl. 1). 132–138. 54 indexed citations
15.
Nishimura, Reiki, Masato Kato, Maki Tanaka, et al.. (2005). Weekly Paclitaxel in the Treatment of Advanced or Metastatic Breast Cancer Previously Treated or Not Treated with Docetaxel: A Phase II Study. Chemotherapy. 51(2-3). 126–131. 9 indexed citations
16.
Kondo, Seiji, et al.. (1994). A Patient with Primary Hypoparathyroidism Developing Hypercalcemia Associated with Adult T-Cell Leukemia/Lymphoma. Leukemia & lymphoma. 14(5-6). 521–525. 3 indexed citations
17.
Ishikawa, Emi, et al.. (1992). Stimulation of cholecystokinin (CCK) release from superfused rat hypothalamo-neurohypophyseal complexes by interleukin-1 (IL-1). Brain Research. 593(1). 25–31. 21 indexed citations
18.
19.
Ishikawa, Emi, et al.. (1990). Activation of mammalian phosphofructokinases by ribose 1,5-bisphosphate.. Journal of Biological Chemistry. 265(31). 18875–18878. 26 indexed citations
20.
Miller, Bonnie C., Emi Ishikawa, Kosaku Uyeda, & G.Larry Cottam. (1989). Endotoxin increases the liver fructose 2,6-bisphosphate concentration in fasted rats. Biochemical and Biophysical Research Communications. 165(3). 1072–1078. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoriko Murata Breakdown of academic impact, for papers by Kyu Ri Son Breakdown of academic impact, for papers by Tao Sun Breakdown of academic impact, for papers by Masato Takahashi Breakdown of academic impact, for papers by Ping Cai Breakdown of academic impact, for papers by Makoto Takeda Breakdown of academic impact, for papers by Alexander Wehr Breakdown of academic impact, for papers by Xiaopan Wu Breakdown of academic impact, for papers by Mark Li Breakdown of academic impact, for papers by Michele Vincitore
Rankless by CCL
2026